By contrast, ATO treatment promoted the accumulation of tumor-infiltrating CD8+ T cells and increased the proportion of IFNγ+ cells in the CD8+ T cell population (Fig. 7G, H and Supplementary Fig. 8B, C). This evidence concerns the gene CD8A and neoplasm.